Inclusion Fluorescent-Antibody Test as a Screening Assay for Detection of Antibodies to Chlamydia pneumoniae
A study was conducted to determine the ability of the inclusion immunofluorescence assay (inclusion IFA) to act as a screening test to detect samples with antibodies to Chlamydia pneumoniae; microimmunofluorescence (MIF) was used as the “gold standard.” In addition, the inclusion IFA was compared us...
Tallennettuna:
| Julkaisussa: | Clin Diagn Lab Immunol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
2002
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC119991/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11986260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/CDLI.9.3.562-567.2002 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
